Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO-SOR study.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);癌, 肝细胞(Carcinoma, Hepatocellular);心血管疾病(Cardiovascular Diseases);人类(Humans);肝肿瘤(Liver Neoplasms);烟酰胺(Niacinamide);苯脲化合物(Phenylurea Compounds);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1111/liv.14941
PMID
33966333
发布时间
2021-08-19
- 浏览2

Liver international
2200-2211页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文